NEXGEL, Inc. (NXGL) stock
NXGLNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as NXGLW
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/3069% below fair value
$3.60−0.19 (-5.13%)
Close on Nov 18, 2026Market cap $1.76MP/E –Yield –
Nexgel price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Nexgel's price to book ratio was 8.3× on Nov 11, 2026, against 56.5× a year earlier. Over the last 5 years it ranged from 6.8× to 327.2×, with a median of 42.7×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 8.3× | −42.2 |
| 2025 | Dec 31, 2025 | 50.6× | −78.7 |
| 2024 | Dec 31, 2024 | 129.2× | +86.5 |
| 2023 | Dec 29, 2023 | 42.7× | +25.8 |
| 2022 | Dec 30, 2022 | 17.0× | −304.4 |
| 2021 | Dec 31, 2021 | 321.3× | – |
See a number that looks wrong?